Overview
In Europe, lung cancer ranks third among the most common cancers, however, it remains the biggest killer. Recent European cancer mortality projections predict a downward trend in most cancer types in both sexes. Worldwide, tobacco use is the single greatest avoidable risk factor for lung cancer mortality. There is a need for integrated prevention action across the life span, combining both primary and secondary prevention. Implementing comprehensive tobacco control policies is paramount in tackling the tobacco uptake by youth, leading to premature mortality. Nevertheless, policies require time to show their results. In the short term, promoting tobacco cessation among current smokers and screening high-risk smokers will have a higher impact in reducing tobacco-related mortality.
Objectives
The aim of this research seminar is to confront experts and young researchers in the field of lung cancer screening and early detection. The seminar aims to offer a platform for interaction between clinicians and researchers involved in different aspects of early detection, including imaging, biomarkers and research on the different aspects of implementation. Young researchers will also be encouraged to present their research projects on these topics.
Participant benefits
- Raise awareness for lung cancer screening among participants.
- Generate hypotheses and stimulate interaction for implementation research.
- Increase involvement in implementation research.
Registration
Registration for this seminar is now open. To register your interest to attend, please complete the online registration form before the deadline on 31 October, 2021.
Please note that participation in this research seminar is upon selection due to the limited number of places available. Notification of selections will be sent by mid-November 2021.